186 related articles for article (PubMed ID: 24206088)
1. Subinhibitory concentrations of tetracyclines induce lipopolysaccharide shedding by Porphyromonas gingivalis and modulate the host inflammatory response.
Tanabe S; Yoshioka M; Hinode D; Grenier D
J Periodontal Res; 2014 Oct; 49(5):603-8. PubMed ID: 24206088
[TBL] [Abstract][Full Text] [Related]
2. Doxycycline reduces lipopolysaccharide-induced inflammatory mediator secretion in macrophage and ex vivo human whole blood models.
Cazalis J; Bodet C; Gagnon G; Grenier D
J Periodontol; 2008 Sep; 79(9):1762-8. PubMed ID: 18771379
[TBL] [Abstract][Full Text] [Related]
3. Porphyromonas gingivalis lipopolysaccharide induces shedding of syndecan-1 expressed by gingival epithelial cells.
Andrian E; Grenier D; Rouabhia M
J Cell Physiol; 2005 Jul; 204(1):178-83. PubMed ID: 15648090
[TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory activity of curcumin in macrophages stimulated by lipopolysaccharides from Porphyromonas gingivalis.
Chen D; Nie M; Fan MW; Bian Z
Pharmacology; 2008; 82(4):264-9. PubMed ID: 18849645
[TBL] [Abstract][Full Text] [Related]
5. A licorice extract reduces lipopolysaccharide-induced proinflammatory cytokine secretion by macrophages and whole blood.
Bodet C; La VD; Gafner S; Bergeron C; Grenier D
J Periodontol; 2008 Sep; 79(9):1752-61. PubMed ID: 18771378
[TBL] [Abstract][Full Text] [Related]
6. Exposure to Porphyromonas gingivalis LPS during macrophage polarisation leads to diminished inflammatory cytokine production.
Belfield LA; Bennett JH; Abate W; Jackson SK
Arch Oral Biol; 2017 Sep; 81():41-47. PubMed ID: 28472719
[TBL] [Abstract][Full Text] [Related]
7. Tetracyclines and chemically modified tetracycline-3 (CMT-3) modulate cytokine secretion by lipopolysaccharide-stimulated whole blood.
Cazalis J; Tanabe S; Gagnon G; Sorsa T; Grenier D
Inflammation; 2009 Apr; 32(2):130-7. PubMed ID: 19238528
[TBL] [Abstract][Full Text] [Related]
8. α-tocopherol decreases interleukin-1β and -6 and increases human β-defensin-1 and -2 secretion in human gingival fibroblasts stimulated with Porphyromonas gingivalis lipopolysaccharide.
Derradjia A; Alanazi H; Park HJ; Djeribi R; Semlali A; Rouabhia M
J Periodontal Res; 2016 Jun; 51(3):295-303. PubMed ID: 26214284
[TBL] [Abstract][Full Text] [Related]
9. Cytokine profiling of macrophages exposed to Porphyromonas gingivalis, its lipopolysaccharide, or its FimA protein.
Zhou Q; Desta T; Fenton M; Graves DT; Amar S
Infect Immun; 2005 Feb; 73(2):935-43. PubMed ID: 15664935
[TBL] [Abstract][Full Text] [Related]
10. Cranberry proanthocyanidins act in synergy with licochalcone A to reduce Porphyromonas gingivalis growth and virulence properties, and to suppress cytokine secretion by macrophages.
Feldman M; Grenier D
J Appl Microbiol; 2012 Aug; 113(2):438-47. PubMed ID: 22563853
[TBL] [Abstract][Full Text] [Related]
11. Oral bacterial DNA differ in their ability to induce inflammatory responses in human monocytic cell lines.
Sahingur SE; Xia XJ; Schifferle RE
J Periodontol; 2012 Aug; 83(8):1069-77. PubMed ID: 22166166
[TBL] [Abstract][Full Text] [Related]
12. Healthy and Inflamed Gingival Fibroblasts Differ in Their Inflammatory Response to Porphyromonas gingivalis Lipopolysaccharide.
Kang W; Hu Z; Ge S
Inflammation; 2016 Oct; 39(5):1842-52. PubMed ID: 27525424
[TBL] [Abstract][Full Text] [Related]
13. Stimulatory effects of glucose and Porphyromonas gingivalis lipopolysaccharide on the secretion of inflammatory mediators from human macrophages.
Hung SL; Lee NG; Chang LY; Chen YT; Lai YL
J Periodontol; 2014 Jan; 85(1):140-9. PubMed ID: 23537124
[TBL] [Abstract][Full Text] [Related]
14. Lipopolysaccharide (LPS) of Porphyromonas gingivalis induces IL-1beta, TNF-alpha and IL-6 production by THP-1 cells in a way different from that of Escherichia coli LPS.
Diya Zhang ; Lili Chen ; Shenglai Li ; Zhiyuan Gu ; Jie Yan
Innate Immun; 2008 Apr; 14(2):99-107. PubMed ID: 18713726
[TBL] [Abstract][Full Text] [Related]
15. Porphyromonas gingivalis lipopolysaccharide weakly activates M1 and M2 polarized mouse macrophages but induces inflammatory cytokines.
Holden JA; Attard TJ; Laughton KM; Mansell A; O'Brien-Simpson NM; Reynolds EC
Infect Immun; 2014 Oct; 82(10):4190-203. PubMed ID: 25047849
[TBL] [Abstract][Full Text] [Related]
16. Xylitol inhibits inflammatory cytokine expression induced by lipopolysaccharide from Porphyromonas gingivalis.
Han SJ; Jeong SY; Nam YJ; Yang KH; Lim HS; Chung J
Clin Diagn Lab Immunol; 2005 Nov; 12(11):1285-91. PubMed ID: 16275942
[TBL] [Abstract][Full Text] [Related]
17. Melatonin Receptor Agonists as the "Perioceutics" Agents for Periodontal Disease through Modulation of Porphyromonas gingivalis Virulence and Inflammatory Response.
Zhou W; Zhang X; Zhu CL; He ZY; Liang JP; Song ZC
PLoS One; 2016; 11(11):e0166442. PubMed ID: 27832188
[TBL] [Abstract][Full Text] [Related]
18. Human β-defensin-3 alleviates the progression of atherosclerosis accelerated by Porphyromonas gingivalis lipopolysaccharide.
Li L; Bian T; Lyu J; Cui D; Lei L; Yan F
Int Immunopharmacol; 2016 Sep; 38():204-13. PubMed ID: 27289299
[TBL] [Abstract][Full Text] [Related]
19. Xylitol, an anticaries agent, exhibits potent inhibition of inflammatory responses in human THP-1-derived macrophages infected with Porphyromonas gingivalis.
Park E; Na HS; Kim SM; Wallet S; Cha S; Chung J
J Periodontol; 2014 Jun; 85(6):e212-23. PubMed ID: 24592909
[TBL] [Abstract][Full Text] [Related]
20. Porphyromonas gingivalis lipopolysaccharide alters atherosclerotic-related gene expression in oxidized low-density-lipoprotein-induced macrophages and foam cells.
Lei L; Li H; Yan F; Li Y; Xiao Y
J Periodontal Res; 2011 Aug; 46(4):427-37. PubMed ID: 21418223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
